Literature DB >> 28492939

Treatment of Macular Edema Due to Central Retinal Vein Occlusion: Another Score for Repackaged Bevacizumab.

Neil M Bressler1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28492939     DOI： 10.1001/jama.2017.5899

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

Review 1.  [Statement of the Professional Association of Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on intravitreal treatment of vision-reducing macular edema by retinal vein occlusion : Treatment strategies, status 24 April 2018].

Authors: 
Journal:  Ophthalmologe       Date:  2018-10       Impact factor: 1.059

2.  Prognostic Factor Study of Macular Edema Recurrence in Retinal Vein Occlusion after Conbercept Treatment: A Post Hoc Analysis of the FALCON Study.

Authors:  Haiying Zhou; Zuhua Sun; Meng Zhao; Xiaoling Liu; Xuan Jiao; Weiwei Zheng; Feng Zhang
Journal:  Comput Math Methods Med       Date:  2022-07-29       Impact factor: 2.809
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.